María del Mar Abad‐Hernández

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression”.

Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression

Cancer Research(2020)10.1158/0008-5472.can-20-0278

N/A

0DataRank · unranked

19 citations

Lourdes Hontecillas‐Prieto, Roberto Corchado‐Cobos, Natalia García‐Sancha, Nélida Salvador, Andrés Castellanos‐Martín +18 more

Data from Stromal SNAI2 Is Required for ERBB2 Breast Cancer Progression

(2023)10.1158/0008-5472.c.6512047.v1

N/A

0DataRank · unranked

0 citations

Lourdes Hontecillas‐Prieto, Roberto Corchado‐Cobos, Natalia García‐Sancha, Nélida Salvador, Andrés Castellanos‐Martín +18 more

A 10-gene signature associated with elevated levels of NCAPH identifies luminal A breast cancer patients with a risk of relapse

Research Square(2023)10.21203/rs.3.rs-3231230/v1

N/A

0DataRank · unranked

0 citations

Natalia García‐Sancha, Roberto Corchado‐Cobos, Angélica Martínez‐López, Hang Chang, Jian‐Hua Mao +18 more

NCAPH Drives Breast Cancer Progression and Identifies a Gene Signature that Predicts Luminal A Tumor Recurrence

Research Square(2023)10.21203/rs.3.rs-3231230/v2

N/A

0DataRank · unranked

0 citations

Natalia García‐Sancha, Roberto Corchado‐Cobos, Angélica Martínez‐López, Hang Chang, Jian‐Hua Mao +18 more

NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence

Clinical and Translational Medicine(2024)10.1002/ctm2.1554

N/A

0DataRank · unranked

7 citations

Natalia García‐Sancha, Roberto Corchado‐Cobos, Angélica Martínez‐López, Hang Chang, Jian‐Hua Mao +18 more